blind multicentre

Related by string. * Bed Liner . BLIND . BLIN . Blind . Blin : blind placebo controlled . Blind Faith . blind eye . blind sided . blind tasting . Blind Side . double blind placebo / Multicentre : multicentre randomized double . multicentre randomized controlled . multicentre randomized . multicentre prospective . randomized multicentre . Canadian Multicentre Osteoporosis . multicentre study * *

Related by context. Frequent words. (Click for all words.) 65 blind randomized 63 blind randomized placebo 62 randomized placebo controlled 60 randomized controlled 59 multicenter randomized double 59 prospective randomized 59 placebo controlled 58 blinded placebo controlled 57 multicentre 56 randomized 56 label dose escalation 56 Randomized 55 multicenter clinical 55 randomized clinical 55 multicenter 54 randomized controlled trial 54 blind placebo controlled 54 randomized controlled clinical 54 phase IIb 53 randomized double 53 double blind placebo 53 Phase 1b clinical 52 dose escalation study 52 randomized Phase III 52 randomized #:# 52 phase IIa 51 placebo controlled trials 51 dose escalation 51 multicenter study 50 Phase IIb clinical 50 randomisation 50 dose escalation trial 50 safety tolerability pharmacokinetics 49 phase 2a 49 Phase 1a 49 unblinded 49 dose regimens 48 Phase Ib 48 prospective cohort 48 composite endpoint 48 Phase III 48 Phase 2b study 48 creatinine clearance 48 Phase 2a clinical 48 Phase 2b clinical 48 Phase IIb 47 Phase 2b 47 Phase 1b 47 randomization 47 bosentan 47 randomized controlled trials 47 randomized trials 47 randomized Phase 47 tolerated dose MTD 47 lacosamide 46 clinical trial 46 echocardiographic 46 randomized clinical trials 46 substudy 46 Phase IIb trial 46 pivotal Phase 46 kinematic 46 pivotal Phase III 46 RECIST criteria 46 tesmilifene 46 single ascending dose 46 abatacept 45 Phase 2b trial 45 evaluable patients 45 vicriviroc 45 dose regimen 45 Phase IIa trial 45 pharmacodynamics 45 Phase 2a trial 45 dose limiting toxicities 45 NRTI 45 RG# [001] 45 Phase IIa 45 multiple ascending dose 45 confirmatory Phase III 45 preoperatively 45 Phase II 45 logistic regression 44 mg BID 44 Phase III clinical 44 electrophysiological 44 telmisartan 44 Phase IIa clinical 44 dabigatran etexilate 44 safety tolerability 44 dose cohorts 44 non inferiority 44 Phase 44 Phase III trials 44 peginterferon alfa 2b 44 prospectively 44 post hoc 43 PRX # 43 RCTs 43 Phase III pivotal 43 TELCYTA

Back to home page